Issue Date: October 10, 2011
Hikma Eyes Morocco With Acquisition
Hikma Pharmaceuticals has acquired 63.9% of Société de Promotion Pharmaceutique du Maghreb (Promopharm) for $112.2 million and is launching a tender offer for the rest of the firm. London-based Hikma says Promopharm is the ninth-largest drugmaker in Morocco, with a 3.5% market share. Its annual sales of about $45 million offer significant growth potential, Hikma says, owing to its portfolio of high-quality branded generics and in-licensed products.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society